First In Human Phase I Trial Of INP20, A Novel Oral Immunotherapy For Peanut Allergy: Safety And Early Immune Modulation
Fields of Study & Subjects
Food Allergy and Anaphylaxis Research
Allergic Rhinitis and Sensitization
Drug-Induced Adverse Reactions
Publication details
- Journal / source
- Journal of Allergy and Clinical Immunology
- Volume
- 157
- Issue
- 2
- Pages
- AB416–AB416
- Publication date
- 1 February 2026
- Language
- EN